News & Events Filter by Category All Portfolio News Portfolio News Inozyme Pharma Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) September 26, 2023 Portfolio News Study Confirming Overwhelming Reduction in Bleeding of the Dual- Acting Factor XI/XIa Inhibitor Abelacimab as Compared to Rivaroxaban Selected as Late- Breaker Oral Presentation at the American Heart Association Scientific Sessions September 26, 2023 Portfolio News Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany September 20, 2023 Portfolio News Atrial Fibrillation Study with Abelacimab Stopped Early by the Data Monitoring Committee Due to an Overwhelming Reduction in Bleeding as Compared to a DOAC (Direct Oral Anticoagulant) September 18, 2023 Portfolio News MapLight Therapeutics Announces Successful Completion of Second Phase 1 Clinical Trial of the Novel Muscarinic Receptor Agonist ML-007 August 24, 2023 Portfolio News OCS-01, First Investigational Eye Drop for Front and Back of the Eye, Met Both Primary Endpoints for the Treatment of Inflammation and Pain Following Cataract Surgery August 08, 2023 Portfolio News Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants July 11, 2023 Portfolio News Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer and Other Leadership Appointments May 23, 2023 Portfolio News Evommune raises $50M to fund clinical trials in skin diseases April 26, 2023 Portfolio News AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline December 06, 2022 Portfolio News Vigil Neuroscience Receives FDA Fast Track Designation for VGL101 for the Treatment of Patients with ALSP November 01, 2022 Portfolio News Vaxcyte Reports Positive Topline Data from Phase 1/2 Proof-of-Concept Study of its 24-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated October 24, 2022 Portfolio News Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss October 18, 2022 Portfolio News Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology October 17, 2022 Portfolio News Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis September 26, 2022 Portfolio News Top-Notch Karuna Therapeutics Breaks Out To Record High On Schizophrenia Win August 08, 2022